Functional transforming growth factor-β receptor type ii expression by cd4 + t cells in peyer's patches is essential for oral tolerance induction

PLoS ONE

Volumn 6, Issue 11, 2011, Pages

  Gilbert, Rebekah S ^a   Kobayashi, Ryoki ^b   Sekine, Shinichi ^c   Fujihashi, Kohtaro ^a,b  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLERA TOXIN; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; OVALBUMIN; PROTEIN SERINE THREONINE KINASE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA TYPE II RECEPTOR; TRANSFORMING GROWTH FACTOR-BETA TYPE II RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CELL FUNCTION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION REGULATION; HELPER CELL; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; LAMINA PROPRIA; LYMPHOCYTE COUNT; MESENTERY LYMPH NODE; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PEYER PATCH; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; ANIMAL; C57BL MOUSE; GENE EXPRESSION; GENETICS; IMMUNOLOGY; METABOLISM; ORAL DRUG ADMINISTRATION;

MUS; MUS MUSCULUS;

ADMINISTRATION, ORAL; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; GENE EXPRESSION; IMMUNE TOLERANCE; MICE; MICE, INBRED C57BL; OVALBUMIN; PEYER'S PATCHES; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SIGNAL TRANSDUCTION;

EID: 80455126062     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0027501     Document Type: Article

References (51)

1. Mestecky J, Blumberg RS, Kiyono H, McGhee JR, (2003) The Mucosal Immune System. In: Paul WE, editors. Fundamental Immunology Sixth Edition ed. Philadelphia Lipincott Williams & Wilkins pp. 965-1021.
2. Mowat AM, Faria AMC, Weiner HL, (2005) Oral Tolerance: Physiological Basis and Clinical Applications. Mucosal Immunology, Volume 1 Burlington, MA Elsevier Academic Press pp. 487-538 Third Edition ed.
3. Smith K, Eaton A, Finlayson L, Garside P, (2000) Oral tolerance. Am J Respir Crit Care Med 162: S175-178.
4. Burks A, Laubach S, Jones S, (2008) Oral tolerance, food allergy, and immunotherapy: implications for future treatment. J Allergy Clin Immunol 121: 1344-1350.
5. Wardrop Rr, Whitacre C, (1999) Oral tolerance in the treatment of inflammatory autoimmune diseases. Inflamm Res 48: 106-119.
6. Faria A, Weiner H, (2006) Oral tolerance: therapeutic implications for autoimmune diseases. Clin Dev Immunol 13: 143-157.
7. Shreffler W, Wanich N, Moloney M, Nowak-Wegrzyn A, Sampson H, (2009) Association of allergen-specific regulatory T cells with the onset of clinical tolerance to milk protein. J Allergy Clin Immunol 123: 43-52.e47.
8. Vickery BP, Scurlock AM, Jones SM, Burks AW, (2011) Mechanisms of immune tolerance relevant to food allergy. J Allergy Clin Immunol 127: 576-584.
9. Allen KJ, Martin PE, (2010) Clinical aspects of pediatric food allergy and failed oral immune tolerance. J Clin Gastroenterol 44: 391-401.
10. Goubier A, Dubois B, Gheit H, Joubert G, Villard-Truc F, et al. (2008) Plasmacytoid dendritic cells mediate oral tolerance. Immunity 29: 464-475.
11. Strober W, (2008) Vitamin A rewrites the ABCs of oral tolerance. Mucosal Immunol 1: 92-95.
12. Shiokawa A, Tanabe K, Tsuji N, Sato R, Hachimura S, (2009) IL-10 and IL-27 producing dendritic cells capable of enhancing IL-10 production of T cells are induced in oral tolerance. Immunol Lett 125: 7-14.
13. Fleur du Pré M, Samsom JN, (2011) Adaptive T-cell responses regulating oral tolerance to protein antigen. Allergy 66: 478-490.
14. Broere F, du Pré MF, van Berkel LA, Garssen J, Schmidt-Weber CB, et al. (2009) Cyclooxygenase-2 in mucosal DC mediates induction of regulatory T cells in the intestine through suppression of IL-4. Mucosal Immunol 2: 254-264.
15. Dubois B, Joubert G, Gomez de Agüero M, Gouanvic M, Goubier A, et al. (2009) Sequential role of plasmacytoid dendritic cells and regulatory T cells in oral tolerance. Gastroenterology 137: 1019-1028.
16. Park KS, Park MJ, Cho ML, Kwok SK, Ju JH, et al. (2009) Type II collagen oral tolerance; mechanism and role in collagen-induced arthritis and rheumatoid arthritis. Mod Rheumatol 19: 581-589.
17. Strobel S, Mowat A, (1998) Immune responses to dietary antigens: oral tolerance. Immunol Today 19: 173-181.
18. Strober W, Kelsall B, Marth T, (1998) Oral tolerance. J Clin Immunol 18: 1-30.
19. Faria A, Weiner H, (2005) Oral tolerance. Immunol Rev 206: 232-259.
20. Whitacre CC, Gienapp IE, Orosz CG, Bitar DM, (1991) Oral tolerance in experimental autoimmune encephalomyelitis. III. Evidence for clonal anergy. J Immunol 147: 2155-2163.
21. Chen Y, Kuchroo VK, Inobe J, Hafler DA, Weiner HL, (1994) Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 265: 1237-1240.
22. Barron L, Knoechel B, Lohr J, Abbas AK, (2008) Cutting edge: contributions of apoptosis and anergy to systemic T cell tolerance. J Immunol 180: 2762-2766.
23. Tsuji N, Mizumachi K, Kurisaki J, (2003) Antigen-specific, CD4+CD25+ regulatory T cell clones induced in Peyer's patches. Int Immunol 15: 525-534.
24. Lohr J, Knoechel B, Abbas A, (2006) Regulatory T cells in the periphery. Immunol Rev 212: 149-162.
25. Fantini MC, Becker C, Monteleone G, Pallone F, Galle PR, et al. (2004) Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7. J Immunol 172: 5149-5153.
26. Tran DQ, Ramsey H, Shevach EM, (2007) Induction of FOXP3 expression in naive human CD4+FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory phenotype. Blood 110: 2983-2990.
27. Chen W, Jin W, Hardegen N, Lei KJ, Li L, et al. (2003) Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 198: 1875-1886.
28. Marie JC, Letterio JJ, Gavin M, Rudensky AY, (2005) TGF-beta1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells. J Exp Med 201: 1061-1067.
29. Huang X, Zhu J, Yang Y, (2005) Protection against autoimmunity in nonlymphopenic hosts by CD4+ CD25+ regulatory T cells is antigen-specific and requires IL-10 and TGF-beta. J Immunol 175: 4283-4291.
30. Derynck R, Feng X, (1997) TGF-beta receptor signaling. Biochim Biophys Acta 1333: F105-150.
31. Chen RH, Moses HL, Maruoka EM, Derynck R, Kawabata M, (1995) Phosphorylation-dependent interaction of the cytoplasmic domains of the type I and type II transforming growth factor-beta receptors. J Biol Chem 270: 12235-12241.
32. Böttinger EP, Jakubczak JL, Haines DC, Bagnall K, Wakefield LM, (1997) Transgenic mice overexpressing a dominant-negative mutant type II transforming growth factor beta receptor show enhanced tumorigenesis in the mammary gland and lung in response to the carcinogen 7,12-dimethylbenz-[a]-anthracene. Cancer Res 57: 5564-5570.
33. Erlebacher A, Filvaroff EH, Ye JQ, Derynck R, (1998) Osteoblastic responses to TGF-beta during bone remodeling. Mol Biol Cell 9: 1903-1918.
34. Amendt C, Schirmacher P, Weber H, Blessing M, (1998) Expression of a dominant negative type II TGF-beta receptor in mouse skin results in an increase in carcinoma incidence and an acceleration of carcinoma development. Oncogene 17: 25-34.
35. Gorelik L, Flavell R, (2000) Abrogation of TGFbeta signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease. Immunity 12: 171-181.
36. Fahlén L, Read S, Gorelik L, Hurst S, Coffman R, et al. (2005) T cells that cannot respond to TGF-beta escape control by CD4(+)CD25(+) regulatory T cells. J Exp Med 201: 737-746.
37. Fujihashi K, Dohi T, Rennert P, Yamamoto M, Koga T, et al. (2001) Peyer's patches are required for oral tolerance to proteins. Proc Natl Acad Sci U S A 98: 3310-3315.
38. Suzuki H, Sekine S, Kataoka K, Pascual D, Maddaloni M, et al. (2008) Ovalbumin-protein sigma 1 M-cell targeting facilitates oral tolerance with reduction of antigen-specific CD4+ T cells. Gastroenterology 135: 917-925.
39. Spahn T, Fontana A, Faria A, Slavin A, Eugster H, et al. (2001) Induction of oral tolerance to cellular immune responses in the absence of Peyer's patches. Eur J Immunol 31: 1278-1287.
40. Spahn T, Weiner H, Rennert P, Lügering N, Fontana A, et al. (2002) Mesenteric lymph nodes are critical for the induction of high-dose oral tolerance in the absence of Peyer's patches. Eur J Immunol 32: 1109-1113.
41. Maeda Y, Noda S, Tanaka K, Sawamura S, Aiba Y, et al. (2001) The failure of oral tolerance induction is functionally coupled to the absence of T cells in Peyer's patches under germfree conditions. Immunobiology 204: 442-457.
42. Walton KL, Galanko JA, Balfour Sartor R, Fisher NC, (2006) T cell-mediated oral tolerance is intact in germ-free mice. Clin Exp Immunol 143: 503-512.
43. Fujihashi K, McGhee JR, Kweon MN, Cooper MD, Tonegawa S, et al. (1996) gamma/delta T cell-deficient mice have impaired mucosal immunoglobulin A responses. J Exp Med 183: 1929-1935.
44. Kato H, Fujihashi K, Kato R, Yuki Y, McGhee JR, (2001) Oral tolerance revisited: prior oral tolerization abrogates cholera toxin-induced mucosal IgA responses. J Immunol 166: 3114-3121.
45. Fujihashi K, McGhee JR, (2005) TH1/TH2/TH3 Cells for Regulation of Mucosal Immunity, Tolerance, and Inflammation. Mucosal Immunology, Volume 1 Burlington, MA Elsevier Academic Press pp. 539-556 Third Edition ed.
46. Zheng SG, Wang J, Wang P, Gray JD, Horwitz DA, (2007) IL-2 is essential for TGF-beta to convert naive CD4+CD25- cells to CD25+Foxp3+ regulatory T cells and for expansion of these cells. J Immunol 178: 2018-2027.
47. Maynard CL, Harrington LE, Janowski KM, Oliver JR, Zindl CL, et al. (2007) Regulatory T cells expressing interleukin 10 develop from Foxp3+ and Foxp3- precursor cells in the absence of interleukin 10. Nat Immunol 8: 931-941.
48. Kweon MN, Fujihashi K, VanCott JL, Higuchi K, Yamamoto M, et al. (1998) Lack of orally induced systemic unresponsiveness in IFN-gamma knockout mice. J Immunol 160: 1687-1693.
49. Fujihashi K, Dohi T, Kweon MN, McGhee JR, Koga T, et al. (1999) gammadelta T cells regulate mucosally induced tolerance in a dose-dependent fashion. Int Immunol 11: 1907-1916.
50. Song F, Wardrop R, Gienapp I, Stuckman S, Meyer A, et al. (2008) The Peyer's patch is a critical immunoregulatory site for mucosal tolerance in experimental autoimmune encephalomylelitis (EAE). J Autoimmunity 30: 230-237.
51. Hauet-Broere F, Unger W, Garssen J, Hoijer M, Kraal G, et al. (2003) Functional CD25- and CD25+ mucosal regulatory T cells are induced in gut-draining lymphoid tissue within 48 h after oral antigen application. Eur J Immunol 33: 2801-2810.